Systolic Versus Diastolic Blood Pressure Versus Pulse Pressure

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2002 Oct 16

PMID 12379164

Citations 5

Authors

William B White

Affiliations

Soon will be listed here.

Abstract

Elevation of systolic blood pressure (BP) has been recognized as an independent risk factor that far exceeds the risk associated with an elevated diastolic BP in older patients with hypertension. Isolated systolic hypertension (ISH) is a disorder typically defined when the systolic BP is greater than 140 mm Hg but with diastolic BP below 90 mm Hg. Pulse pressure (the difference between systolic and diastolic pressure) has recently become an active area of discussion in the literature as an independent factor of cardiovascular risk. An increased pulse pressure nearly always indicates reduced vascular compliance of large arteries and, by definition, is always increased in patients with isolated systolic hypertension. Although the evidence that a widened pulse pressure is an independent marker of cardiovascular risk is quite well established, therapeutic morbidity and mortality studies in ISH have focused on reductions in systolic pressure. At the present time, outcomes data have not been well established for reductions in pulse pressure in older patients with hypertension.

Citing Articles

Effect of fixed 7.5 minutes' moderate intensity exercise bouts on body composition and blood pressure among sedentary adults with prehypertension in Western-Kenya.

Magutah K, Mbuthia G, Akiruga J, Haile D, Thairu K PLOS Glob Public Health. 2023; 2(7):e0000806.

PMID: 36962441 PMC: 10021634. DOI: 10.1371/journal.pgph.0000806.

Changes in Retinal Optical Coherence Tomography Angiography Indexes Over 24 Hours.

Lal B, Alonso-Caneiro D, Read S, Tran B, Van Bui C, Tang D Invest Ophthalmol Vis Sci. 2022; 63(3):25.

PMID: 35348589 PMC: 8976927. DOI: 10.1167/iovs.63.3.25.

Impact of gender and blood pressure on poststroke cognitive decline among older Latinos.

Levine D, Haan M, Langa K, Morgenstern L, Neuhaus J, Lee A J Stroke Cerebrovasc Dis. 2012; 22(7):1038-45.

PMID: 22748715 PMC: 4030756. DOI: 10.1016/j.jstrokecerebrovasdis.2012.05.004.

Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people.

White W, Wolfson L, Wakefield D, Hall C, Campbell P, Moscufo N Circulation. 2011; 124(21):2312-9.

PMID: 22105196 PMC: 3235794. DOI: 10.1161/CIRCULATIONAHA.111.037036.

Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease.

Garcia-Donaire J, Ruilope L Curr Hypertens Rep. 2010; 12(4):307-12.

PMID: 20640944 DOI: 10.1007/s11906-010-0129-z.

References

Stamler J, STAMLER R, Neaton J . Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993; 153(5):598-615. DOI: 10.1001/archinte.153.5.598. View

Staessen J, Fagard R, Thijs L, Celis H, Arabidze G, Birkenhager W . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350(9080):757-64. DOI: 10.1016/s0140-6736(97)05381-6. View

. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265(24):3255-64. View

Staessen J, Thijs L, Fagard R, OBrien E, Clement D, de Leeuw P . Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999; 282(6):539-46. DOI: 10.1001/jama.282.6.539. View

White W . The systolic blood pressure versus pulse pressure controversy. Am J Cardiol. 2001; 87(11):1278-81. DOI: 10.1016/s0002-9149(01)01519-3. View

Stallard M, Park G, Stewart W, Waller E, Covinsky J . Systolic blood pressure response in three subgroups of hypertensives treated with sustained-release diltiazem. J Cardiovasc Pharmacol. 1988; 12 Suppl 6:S117-9. DOI: 10.1097/00005344-198812006-00029. View

Benetos A, Safar M, Rudnichi A, SMULYAN H, Richard J, Ducimetieere P . Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997; 30(6):1410-5. DOI: 10.1161/01.hyp.30.6.1410. View

Antikainen R, Jousilahti P, Vanhanen H, Tuomilehto J . Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure. J Hypertens. 2000; 18(4):417-23. DOI: 10.1097/00004872-200018040-00010. View

Leonetti G, Trimarco B, COLLATINA S, Tosetti A . An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril. Am J Hypertens. 1997; 10(10 Pt 2):230S-235S. DOI: 10.1016/s0895-7061(97)00328-2. View

10.

Benetos A, Zureik M, Morcet J, Thomas F, Bean K, Safar M . A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol. 2000; 35(3):673-80. DOI: 10.1016/s0735-1097(99)00586-0. View

11.

. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000; 283(15):1967-75. View

12.

Vardan S, Mookherjee S . Perspectives on isolated systolic hypertension in elderly patients. Arch Fam Med. 2000; 9(4):319-23. DOI: 10.1001/archfami.9.4.319. View

13.

PORT S, Demer L, Jennrich R, Walter D, Garfinkel A . Systolic blood pressure and mortality. Lancet. 2000; 355(9199):175-80. DOI: 10.1016/S0140-6736(99)07051-8. View

14.

SMULYAN H, Safar M . The diastolic blood pressure in systolic hypertension. Ann Intern Med. 2000; 132(3):233-7. DOI: 10.7326/0003-4819-132-3-200002010-00010. View

15.

. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997; 157(21):2413-46. DOI: 10.1001/archinte.157.21.2413. View

16.

Cruickshank J . Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988; 297(6658):1227-30. PMC: 1834729. DOI: 10.1136/bmj.297.6658.1227. View

17.

Black H, Elliott W, Neaton J, Grandits G, Grambsch P, Grimm Jr R . Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension. 2001; 37(1):12-18. DOI: 10.1161/01.hyp.37.1.12. View

18.

Weber M . Emerging treatments for hypertension: potential role for vasopeptidase inhibition. Am J Hypertens. 1999; 12(11 Pt 2):139S-147S. DOI: 10.1016/s0895-7061(99)00205-8. View

19.

White W . Benefits of antihypertensive therapy in older patients with hypertension. Arch Intern Med. 2000; 160(2):149-50. DOI: 10.1001/archinte.160.2.149. View

20.

Hansson L, Zanchetti A, Carruthers S, Dahlof B, Elmfeldt D, Julius S . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998; 351(9118):1755-62. DOI: 10.1016/s0140-6736(98)04311-6. View